Patients with HIV are living longer, which means that physicians often need to factor diabetes into care strategy. Also today, better communication between ICU staff and family may improve end-of-life choices, randomized clinical trials for probiotics often lack adequate safety data, and early data suggest that intranasal naloxone is promising for hypoglycemia-associated autonomic failure (HAAF). Listen to the MDedge Daily News for today’s top news.
We noticed you have an ad blocker enabled. Please whitelist us so we can continue to provide free content.